Loading clinical trials...
Loading clinical trials...
The Use of Deoxyhemoglobin Concentration Changes as a Non-invasive Contrast Alternative for Cerebral Perfusion Imaging
Conditions
Interventions
dHb contrast and gadolinium contrast imaging
Locations
1
Canada
Joseph Fisher
Toronto, Ontario, Canada
Start Date
August 1, 2021
Primary Completion Date
September 1, 2021
Completion Date
March 1, 2022
Last Updated
April 27, 2021
NCT06258538
NCT07371455
NCT05093673
NCT06870812
NCT07253181
NCT05147792
Lead Sponsor
University Health Network, Toronto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions